|
|
|
|
| Join Cell & Gene Live for "Scaling Next-Gen MSC Therapies Without Scaling Risk." Chief Editor Erin Harris hosts CEOs from Kiji Therapeutics, Mesoblast, and MEDIPOST to explore scaling cell production without losing therapeutic efficacy. Learn practical strategies for minimizing donor variability, preserving potency, and building commercially viable platforms. Don't risk clinical success—register for free today to secure your spot! |
|
|
|
Webinar | Invetech | Delve into the dynamic transition towards automation in cell and gene therapy manufacturing as well as the challenges it presents to start ups with industry experts in this webinar. |
|
|
|
Webinar | Andelyn Biosciences | Biotech visibility improves through real-time data and centralized platforms, enabling collaboration, faster decisions, reduced risk, and better partner alignment. |
|
|
|
Video | Charter Medical | Learn about an Innovation Hub that specializes in freezing studies to provide insight into the performance of single-use cryopreservation solutions for manufacturing and delivering advanced therapies. |
|
|
|
Webinar | MilliporeSigma | Novel analytical methods can measure multiple critical quality attributes in a single run, conserving precious viral vector volume while maintaining comprehensive characterization standards. |
|
|
|
Video | Cell & Gene | During this first segment of Cell & Gene Live, Solving Vector Yield Challenges in In Vivo CGT, Karen Kozarsky, Ph.D., President and CSO of Vector BioPartners, and Robert Bell, Ph.D., CSO of Ascidian Therapeutics, define the industry's biggest challenge in balancing biological performance with manufacturability. |
|
|
|
Webinar | Veristat, Inc. | The weeks after database lock often stall reporting. Here's how automated, deterministic TLF generation speeds up that timeline. |
|
|
| Connect With Cell & Gene: |
|
|
|
